Colgate's Pet Nutrition Shines Amid Stagnant Core Growth and Overvaluation

What happened

Colgate-Palmolive's Q2 2025 results showed only 1% sales growth with flat volume and a 9% operating profit decline in North America, highlighting broader challenges. However, the Hill's Pet Nutrition segment has reportedly outperformed in a soft market, gaining share through prescription diets, cat growth, and science-led innovation. This positive momentum in Pet Nutrition, which accounts for about 22% of sales, contrasts with the sluggish performance in the larger Oral, Personal and Home Care segment. While management may tout this success, investors should critically assess if it can sustainably offset overvaluation at 18% above intrinsic value and persistent margin pressures. Ultimately, the company's overall health depends on whether Pet Nutrition's strength can drive meaningful organic growth without being undermined by FX exposure and core segment struggles.

Implication

The strength in Pet Nutrition could support near-term earnings if sustained, providing a partial offset to challenges in oral care. Investors should monitor whether this momentum is durable or a short-lived boost in a competitive market. However, with the stock trading 18% above DCF value and North America margins under pressure, upside remains limited without broader volume recovery. The overvaluation risks are compounded by FX volatility and emerging market exposure, which could dampen overall profitability. Thus, while Pet Nutrition is a positive data point, it doesn't fundamentally alter the risk/reward profile, emphasizing the need for vigilance on organic sales trends and margin improvements across all segments.

Thesis delta

The news reinforces Pet Nutrition's role as a growth driver, aligning with management's focus on science-led innovation. However, it does not mitigate the overvaluation or core segment weaknesses, so the thesis of a HOLD rating remains intact. Investors should watch for sustained momentum in Pet Nutrition alongside signs of recovery in oral care to consider any upgrade.